N-Power Medicine raised a $32M Series B to expand its community oncology research network and adoption of its ProECA technology.
- Amount
- $32M
- Stage
- Series B
- Announced
- 1 September 2026
- Investors
- Labcorp Venture Fund, Merck Global Health Innovation Fund, Innovatus Capital Partners
- Use of funds
- Scale its community oncology clinical research network and expand biopharma adoption of its ProECA technology.
- Checked
- Amount and date checked against the press source